Source link : https://newshealth.biz/health-news/refractory-mcl-mosunetuzumab-polatuzumab-combo-effective/
In an otherwise treatment-refractory population, the combination shows favorable overall response rates in patients with mantle cell lymphoma. Medscape Medical News Source link : https://www.medscape.com/viewarticle/refractory-mantle-cell-lymphoma-mosunetuzumab-polatuzumab-2025a1000nsk?src=rss Author : Publish date : 2025-09-09 13:33:00 Copyright for syndicated content belongs to the linked Source.
The post Refractory MCL: Mosunetuzumab-Polatuzumab Combo Effective first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-09 13:33:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8